Medical Portal

According to the large research which has been carried out in the USA, regular aspirin taking reduces cancer risk and the death rate connected to the oncological reasons, in particular it concerns former smokers and those who have never smoked. Only aspirin has this effect, and it is not extended on the other nonsteroidal anti-inflammatory drugs, (NSAID).
«Most likely, aspirin has anticarcinogenic properties, but it has side effects, as well, for example, it can provoke a gastric bleeding. Before starting to take aspirin, it is necessary to consult to the doctor», - warns the author of the work Aditya Bardia (clinic Mayo, Rochester, the USA).
Researcher used the data on 22507 women. Study lasted for 12 years, during this time 3487 women suffered cancer, 1193 from them have died for this reason. Regular aspirin taking reduced risk of cancer by 16 % and lowered risk of death from oncological disease by13 %.
Aspirin also reduces risk of death from cardiovascular diseases and the general death rate.
Aditya Bardia has named the received data intriguing, as they are evidence that «regular taking of aspirin can play the important role in prevention of chronic diseases most spread in the western countries, that is a cancer and heart ischemic illness».